Comparing ultrasound and fluoroscopy for knee pain treatment
Official title: Fluoroscopic Versus Ultrasound Guidance for Cooled Radiofrequency Ablation of Geniculate Nerves in Knee Osteoarthritis: A Randomized Control Trial
Run by University of California, Davis · NCT04472702 · Data updated 2026-11-12
This study tests whether using ultrasound or fluoroscopy to guide a knee pain treatment can help people with knee osteoarthritis feel less pain and improve their function when other treatments haven't worked.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 35 Years to 99 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | University of California, Davis Academic / other |
| Locations | 2 sites (Sacramento, California and 1 other locations) |
| Status | Recruiting |
| Started | February 2, 2022 |
| Main results expected | May 1, 2027 |
| Study ends | May 1, 2027 |
| Registry record updated | June 16, 2026 |
| Trial ID | NCT04472702 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with knee osteoarthritis who have not found relief from standard treatments and have a Kellgren-Lawrence score of 2-4.
✕Probably not a fit
Patients under 35 years old, those with a BMI over 40, or individuals who have previously undergone knee radiofrequency ablation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to compare the effectiveness of cooled radiofrequency ablation (cRFA) of the geniculate nerves in patients with knee osteoarthritis using two different guidance methods: fluoroscopy and ultrasound. The study will enroll patients who have not responded to conventional treatments and will assess outcomes such as pain levels and functional improvement. Participants will be randomized into two groups, receiving either ultrasound or fluoroscopic guidance for their cRFA treatment. The trial will also explore additional measures, including biomarkers related to inflammation and cartilage health.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management and functional outcomes for patients with knee osteoarthritis.
How similar studies have gone: While there are few studies directly comparing these two guidance methods, the approach of using ultrasound for nerve targeting is gaining interest and may offer advantages over traditional methods.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1\) patients of either gender with primary knee OA of one or both knees fulfilling the diagnostic criteria for knee OA by the American College of Rheumatology, * 2\) Kellgren-Lawrence score of two to four, * 3\) reported NPRS pain intensity of at least four on most or all days of the past week * 4\) pain resistant to conventional treatments which may include but is not limited to medications (e.g. acetaminophen, oral or topical non-steroidal anti-inflammatory drugs, opioids), physical therapy, and intra-articular injections (e.g. corticosteroids, hyaluronic acid, platelet-rich-plasma) for at least 3 months. In the case of bilateral knee OA, the most symptomatic knee will be treated and studied. Exclusion Criteria: * 1\) age \<35 years, * 2\) non-English speaking patients, * 3\) body mass index greater than 40, * 4\) previous radiofrequency ablation procedure for the knee, * 5\) active systemic or local infections at the site of needle/cRFA probe placement, * 6\) previous knee joint replacement surgery, * 7\) autoimmune or inflammatory cause of knee arthritis such as rheumatoid or psoriatic arthritis, * 8\) non-ambulatory patients, * 9\) patients who are unable to provide their own consent (e.g. dementia), * 10\) unstable medical or psychiatric illness, * 11\) patients with pacemakers, spinal cord stimulators, deep brain stimulators, or similar devices, * 12\) patients seeking care as a part of workman's compensation or have litigation pending * 13\) a negative response to diagnostic geniculate nerve lidocaine injections.
Where it's running
-
University of Rochester
Rochester, New York, United States Recruiting -
UC Davis Health
Sacramento, California, United States Not yet recruiting
Study contacts
- Principal investigator: Daniel Herman, MD — University of California, Davis
- Study coordinator: Daniel Herman, MD
- Email: dcherman@ucdavis.edu
- Phone: 916-734-6805
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of virtual reality on walking in adults with knee osteoarthritis
This study tests how immersive virtual reality environments—designed to feel safe or to provoke fear—affect walking and worry about movement in adults 50 and older with knee osteoarthritis and in healthy peers.
-
Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese
This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Preoperative Multimorbidity and Functional Recovery After Total Knee Arthroplasty
This study tests whether higher burden of preoperative multimorbidity affects functional recovery after knee replacement in adults with knee osteoarthritis.
-
Cartilage biomarker response to acute loading in knee OA by antiresorptive treatment status
Researchers will test whether a 30-minute treadmill walk changes cartilage biomarkers in postmenopausal women with knee osteoarthritis, comparing those on denosumab, bisphosphonates, and those not on antiresorptives.
-
Lysyl Enzymes in Knee Osteoarthritis
This study tests whether blood levels of lysyl hydroxylase and lysyl oxidase differ between people with knee osteoarthritis and healthy individuals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.